Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

businesswire.com
ABCL The article announces AbCellera's participation in upcoming investor conferences in May and June 2026. This is an informational update for investors and does not provide specific performance indicators or strategic insights.

AbCellera to Present at Upcoming Investor Conferences in May and June 2026 VANCOUVER, British Columbia--( BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com.